Sara Bar‐Yehuda

2.3k total citations
33 papers, 2.0k citations indexed

About

Sara Bar‐Yehuda is a scholar working on Physiology, Oncology and Molecular Biology. According to data from OpenAlex, Sara Bar‐Yehuda has authored 33 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Physiology, 11 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Sara Bar‐Yehuda's work include Adenosine and Purinergic Signaling (27 papers), Peptidase Inhibition and Analysis (10 papers) and NF-κB Signaling Pathways (5 papers). Sara Bar‐Yehuda is often cited by papers focused on Adenosine and Purinergic Signaling (27 papers), Peptidase Inhibition and Analysis (10 papers) and NF-κB Signaling Pathways (5 papers). Sara Bar‐Yehuda collaborates with scholars based in Israel, United States and Netherlands. Sara Bar‐Yehuda's co-authors include Pnina Fishman, Lea Madi, Faina Barer, Avivit Ochaion, Gil Ohana, Kenneth A. Jacobson, Bruce T. Liang, Shira Cohen, Lea Rath‐Wolfson and Ilan Cohn and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Clinical Cancer Research.

In The Last Decade

Sara Bar‐Yehuda

33 papers receiving 1.9k citations

Peers

Countries citing papers authored by Sara Bar‐Yehuda

Since Specialization

Citations

This map shows the geographic impact of Sara Bar‐Yehuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Bar‐Yehuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Bar‐Yehuda more than expected).

Fields of papers citing papers by Sara Bar‐Yehuda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Bar‐Yehuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Bar‐Yehuda. The network helps show where Sara Bar‐Yehuda may publish in the future.

Co-authorship network of co-authors of Sara Bar‐Yehuda

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Bar‐Yehuda. A scholar is included among the top collaborators of Sara Bar‐Yehuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Bar‐Yehuda. Sara Bar‐Yehuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hospital staff perspectives towards health technology assessment: data from a multidisciplinary survey 2019 ·Health Research Policy and Systems ·Orna Tal, (unknown), Sara Bar‐Yehuda	9
2	Antithrombotic Treatment Prior to Intracerebral Hemorrhage: Analysis in the National Acute Stroke Israeli Registry 2018 ·Journal of Stroke and Cerebrovascular Diseases ·(unknown), David Tanné, Diklah Geva, (unknown), Shlomo Nir, Sara Bar‐Yehuda, Sagi Harnof	7
3	Targeting the A3 adenosine receptor for glaucoma treatment (Review) 2013 ·Molecular Medicine Reports ·Pnina Fishman, Shira Cohen, Sara Bar‐Yehuda	25
4	Pharmacological and therapeutic effects of A 3 adenosine receptor agonists 2012 ·Pnina Fishman, Sara Bar‐Yehuda, Bruce T. Liang, Kenneth A. Jacobson	16
5	Putative role of the adenosine A3 receptor in the antiproliferative action of N 6-(2-isopentenyl)adenosine 2011 ·Purinergic Signalling ·Clara C. Blad, Jacobien K. von Frijtag Drabbe Künzel, Henk de Vries, Thea Mulder‐Krieger, Sara Bar‐Yehuda, Pnina Fishman, Adriaan P. IJzerman	16
6	The anti-inflammatory effect of A₃adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis 2007 ·Expert Opinion on Investigational Drugs ·Sara Bar‐Yehuda, Michael H. Silverman, William Kerns, Avivit Ochaion, Shira Cohen, Pnina Fishman	77
7	Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kappaB in mediating receptor level. 2007 ·PubMed ·Lea Madi, Shira Cohen, (unknown), Sara Bar‐Yehuda, Faina Barer, Pnina Fishman	64
8	The PI3K–NF-κB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis 2006 ·Arthritis Research & Therapy ·Pnina Fishman, Sara Bar‐Yehuda, Lea Madi, Lea Rath‐Wolfson, Avivit Ochaion, Shira Cohen, Ehud Baharav	79
9	Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3adenosine receptor expression 2006 ·Arthritis Research & Therapy ·Avivit Ochaion, Sara Bar‐Yehuda, (unknown), Luis Del Valle, (unknown), Lea Madi, Faina Barer, Motti Farbstein, (unknown), Tatiana Reitblat, (unknown), Howard Amital, Y Levi, Yair Molad, Reuven Mader, Moshe Tishler, Pnina Langevitz, (unknown), Pnina Fishman	51
10	CF101, An Agonist to the A3 Adenosine Receptor, Enhances the Chemotherapeutic Effect of 5-Fluorouracil in a Colon Carcinoma Murine Model 2005 ·Neoplasia ·Sara Bar‐Yehuda, Lea Madi, Daniel Silberman, (unknown), (unknown), Pnina Fishman	41
11	An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3β and NF-κB 2003 ·Oncogene ·Pnina Fishman, Sara Bar‐Yehuda, Gil Ohana, Faina Barer, Avivit Ochaion, (unknown), Lea Madi	85
12	A3 Adenosine Receptor Activation in Melanoma Cells 2003 ·Journal of Biological Chemistry ·Lea Madi, Sara Bar‐Yehuda, Faina Barer, (unknown), Avivit Ochaion, Pnina Fishman	80
13	Pharmacology and Therapeutic Applications of A3 Receptor Subtype 2003 ·Current Topics in Medicinal Chemistry ·Pnina Fishman, Sara Bar‐Yehuda	68
14	Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells 2002 ·Oncogene ·Pnina Fishman, Lea Madi, Sara Bar‐Yehuda, Faina Barer, Luis Del Valle, Kamel Khalili	88
15	Agonists to the A3 adenosine receptor induce G-CSF production via NF-κB activation 2002 ·Experimental Hematology ·Sara Bar‐Yehuda, Lea Madi, (unknown), Moshe Mittelman, (unknown), Avivit Ochaion, (unknown), Pnina Fishman	60
16	The A3 Adenosine Receptor as a New Target for Cancer Therapy and Chemoprotection 2001 ·Experimental Cell Research ·Pnina Fishman, Sara Bar‐Yehuda, Faina Barer, Lea Madi, Asha S. Multani, Sen Pathak	105
17	Resistance of Muscle to Tumor Metastases: A Role for A3 Adenosine Receptor Agonists 2001 ·Neoplasia ·Sara Bar‐Yehuda, Faina Barer, (unknown), Pnina Fishman	72
18	Adenosine acts as a chemoprotective agent by stimulating G-CSF production: A role for A1 and A3 adenosine receptors 2000 ·Journal of Cellular Physiology ·Pnina Fishman, Sara Bar‐Yehuda, (unknown), Faina Barer, Gil Ohana	50
19	Differential effect of adenosine on tumor and normal cell growth: Focus on the A3 adenosine receptor 2000 ·Journal of Cellular Physiology ·Gil Ohana, Sara Bar‐Yehuda, Faina Barer, Pnina Fishman	108
20	Oral administration of muscle derived small molecules inhibits tumor spread while promoting normal cell growth in mice 1999 ·Clinical & Experimental Metastasis ·Sara Bar‐Yehuda, (unknown), Faina Barer, Gil Ohana, Pnina Fishman	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact